Drug & medication recalls Moderate risk

Cefuroxime recalled over sterility concerns

Recall date
December 6, 2021
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Edge Pharma, LLC recalls Cefuroxime, Sterile Ophthalmic Solution for Injection, Preservative Free, 3mg/0.3mL (10 mg/mL), 0.3 mL single use syrin…
Recall number
D-0398-2022
FDA classification
Class II
Brand / firm
Edge Pharma, LLC
Sold / distributed
nationwide

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Cefuroxime, Sterile Ophthalmic Solution for Injection, Preservative Free, 3mg/0.3mL (10 mg/mL), 0.3 mL single use syringe for Intraocular Injection, Edge Pharma, LLC, 656 Hercules Dr., Colchester, VT 05446 NDC 05446-1003-01

Get recall alerts

Free email alert whenever Edge Pharma, LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Edge Pharma, LLC